Dr. Nami Khulusi, MD (he/him) is a Internist in Eatontown, NJ with over 18 years of experience. What is your opinion of Dr. Nami Khulusi, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Nami Khulusi, MD has received over $10,896 which includes payments from the following companies:
$1,843.71 from AstraZeneca Pharmaceuticals LP
$1,828.23 from Novo Nordisk Inc
$815.64 from Janssen Pharmaceuticals, Inc
$669.84 from Merck Sharp & Dohme Corporation
$652.98 from Takeda Pharmaceuticals America, Inc.
$506.62 from Boehringer Ingelheim Pharmaceuticals, Inc.
$433.67 from Kowa Pharmaceuticals America, Inc.
$364.96 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$351.28 from LILLY USA, LLC
$339.16 from GlaxoSmithKline, LLC.
$238.35 from Pfizer Inc.
$219.10 from Valeant Pharmaceuticals North America LLC
$213.69 from Amarin Pharma Inc.
$205.87 from Eisai Inc.
$198.97 from Daiichi Sankyo Inc.
$177.13 from Endo Pharmaceuticals Inc.
$169.09 from Orexigen Therapeutics, Inc.
$132.42 from Takeda Pharmaceuticals U.S.A., Inc.
$121.94 from Novartis Pharmaceuticals Corporation
$111.68 from Allergan Inc.
Payments received by Dr. Nami Khulusi, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!